Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psycholog… Read more
Narayana Hrudayalaya Ltd. (NH) - Net Assets
Latest net assets as of September 2025: ₹40.62 Billion INR
Based on the latest financial reports, Narayana Hrudayalaya Ltd. (NH) has net assets worth ₹40.62 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹77.42 Billion) and total liabilities (₹36.80 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹40.62 Billion |
| % of Total Assets | 52.47% |
| Annual Growth Rate | 15.53% |
| 5-Year Change | 223.71% |
| 10-Year Change | 309.0% |
| Growth Volatility | 13.81 |
Narayana Hrudayalaya Ltd. - Net Assets Trend (2011–2025)
This chart illustrates how Narayana Hrudayalaya Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Narayana Hrudayalaya Ltd. (2011–2025)
The table below shows the annual net assets of Narayana Hrudayalaya Ltd. from 2011 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹36.28 Billion | +25.76% |
| 2024-03-31 | ₹28.85 Billion | +35.30% |
| 2023-03-31 | ₹21.32 Billion | +43.18% |
| 2022-03-31 | ₹14.89 Billion | +32.88% |
| 2021-03-31 | ₹11.21 Billion | -1.38% |
| 2020-03-31 | ₹11.36 Billion | +5.08% |
| 2019-03-31 | ₹10.82 Billion | +4.39% |
| 2018-03-31 | ₹10.36 Billion | +7.55% |
| 2017-03-31 | ₹9.63 Billion | +8.59% |
| 2016-03-31 | ₹8.87 Billion | +15.89% |
| 2015-03-31 | ₹7.65 Billion | +31.25% |
| 2014-03-31 | ₹5.83 Billion | +5.64% |
| 2013-03-31 | ₹5.52 Billion | +6.75% |
| 2012-03-31 | ₹5.17 Billion | +7.52% |
| 2011-03-31 | ₹4.81 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Narayana Hrudayalaya Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3142.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹27.46 Billion | 75.73% |
| Common Stock | ₹2.04 Billion | 5.64% |
| Other Comprehensive Income | ₹1.70 Billion | 4.70% |
| Other Components | ₹5.05 Billion | 13.93% |
| Total Equity | ₹36.26 Billion | 100.00% |
Narayana Hrudayalaya Ltd. Competitors by Market Cap
The table below lists competitors of Narayana Hrudayalaya Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SKC Co. Ltd
KO:011790
|
$1.26 Billion |
|
FAIRFAX INDIA HLDGS
F:F5X
|
$1.26 Billion |
|
DEME Group NV
BR:DEME
|
$1.26 Billion |
|
Guangzhou Haozhi Industrial Co Ltd
SHE:300503
|
$1.26 Billion |
|
Jiangsu Hualan New Pharmaceutical Material Co. Ltd.
SHE:301093
|
$1.26 Billion |
|
Primaris Real Estate Investment Trust
PINK:PMREF
|
$1.26 Billion |
|
YGSOFT Inc
SHE:002063
|
$1.26 Billion |
|
Stadler Rail AG
PINK:SRAIF
|
$1.26 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Narayana Hrudayalaya Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 28,836,810,000 to 36,263,550,000, a change of 7,426,740,000 (25.8%).
- Net income of 7,901,550,000 contributed positively to equity growth.
- Dividend payments of 812,400,000 reduced retained earnings.
- Other comprehensive income increased equity by 337,590,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹7.90 Billion | +21.79% |
| Dividends Paid | ₹812.40 Million | -2.24% |
| Other Comprehensive Income | ₹337.59 Million | +0.93% |
| Total Change | ₹- | 25.75% |
Book Value vs Market Value Analysis
This analysis compares Narayana Hrudayalaya Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.28x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 70.41x to 9.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | ₹23.53 | ₹1657.00 | x |
| 2012-03-31 | ₹25.22 | ₹1657.00 | x |
| 2013-03-31 | ₹29.06 | ₹1657.00 | x |
| 2014-03-31 | ₹30.83 | ₹1657.00 | x |
| 2015-03-31 | ₹40.06 | ₹1657.00 | x |
| 2016-03-31 | ₹43.55 | ₹1657.00 | x |
| 2017-03-31 | ₹47.48 | ₹1657.00 | x |
| 2018-03-31 | ₹51.02 | ₹1657.00 | x |
| 2019-03-31 | ₹53.28 | ₹1657.00 | x |
| 2020-03-31 | ₹55.95 | ₹1657.00 | x |
| 2021-03-31 | ₹55.21 | ₹1657.00 | x |
| 2022-03-31 | ₹73.30 | ₹1657.00 | x |
| 2023-03-31 | ₹104.94 | ₹1657.00 | x |
| 2024-03-31 | ₹141.98 | ₹1657.00 | x |
| 2025-03-31 | ₹178.55 | ₹1657.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Narayana Hrudayalaya Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 21.79%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.41%
- • Asset Turnover: 0.75x
- • Equity Multiplier: 2.00x
- Recent ROE (21.79%) is above the historical average (9.79%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 2.84% | 2.86% | 0.68x | 1.46x | ₹-344.53 Million |
| 2012 | 5.00% | 3.92% | 0.84x | 1.52x | ₹-257.80 Million |
| 2013 | 4.53% | 2.95% | 0.87x | 1.76x | ₹-299.06 Million |
| 2014 | 5.46% | 2.89% | 0.95x | 1.99x | ₹-263.32 Million |
| 2015 | -2.19% | -1.23% | 1.00x | 1.78x | ₹-932.41 Million |
| 2016 | 2.39% | 1.31% | 1.13x | 1.61x | ₹-674.50 Million |
| 2017 | 8.62% | 4.40% | 1.15x | 1.71x | ₹-132.55 Million |
| 2018 | 4.96% | 2.24% | 0.90x | 2.45x | ₹-522.28 Million |
| 2019 | 5.47% | 2.06% | 1.09x | 2.44x | ₹-489.45 Million |
| 2020 | 10.47% | 3.79% | 1.08x | 2.55x | ₹53.20 Million |
| 2021 | -1.28% | -0.55% | 0.93x | 2.47x | ₹-1.26 Billion |
| 2022 | 22.97% | 9.24% | 1.18x | 2.10x | ₹1.93 Billion |
| 2023 | 28.44% | 13.38% | 1.09x | 1.95x | ₹3.93 Billion |
| 2024 | 27.37% | 16.14% | 0.87x | 1.95x | ₹5.01 Billion |
| 2025 | 21.79% | 14.41% | 0.75x | 2.00x | ₹4.28 Billion |
Industry Comparison
This section compares Narayana Hrudayalaya Ltd.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $12,693,693,925
- Average return on equity (ROE) among peers: 6.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Narayana Hrudayalaya Ltd. (NH) | ₹40.62 Billion | 2.84% | 0.91x | $1.26 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $48.02 Billion | 3.13% | 1.38x | $8.72 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $8.87 Billion | 5.90% | 0.85x | $1.48 Billion |
| Fortis Healthcare Limited (FORTIS) | $40.85 Billion | 1.77% | 2.04x | $4.64 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $37.86 Million |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $307.57 Million |
| Indraprastha Medical Corporation Limited (INDRAMEDCO) | $1.59 Billion | 16.95% | 1.52x | $183.78 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.37 Billion | 12.52% | 1.55x | $345.52 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $14.11 Billion | 23.58% | 0.35x | $1.77 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $7.74 Million |
| Max Healthcare Institute Limited (MAXHEALTH) | $5.49 Billion | -11.78% | 1.33x | $7.97 Billion |